VEGFC and neoplasm: Two studies using soluble tumor-excreted sVEGFR3-Ig as a decoy receptor for ligands VEGF-C and VEGF-D showed reduced tumor lymphatic proliferation and lymph node metastasis in mice and rats, respectively [89,90].